Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model
在新辅助治疗中同时使用 H-铁蛋白-阿霉素和曲妥珠单抗可提高 HER2 + 小鼠乳腺癌模型的疗效并预防心脏毒性
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-020-68205-w
F Andreata #, A Bonizzi #, M Sevieri, M Truffi, M Monieri, L Sitia, F Silva, L Sorrentino, R Allevi, P Zerbi, B Marchini, E Longhi, R Ottria, S Casati, R Vanna, C Morasso, M Bellini, D Prosperi, F Corsi, S Mazzucchelli
